Nandrolone Pregnancy and Breastfeeding Warnings
Brand names: Anabolin LA, Androlone-D, Andryl 200, Deca-Durabolin, Durabolin, Durabolin 50, Hybolin Decanoate, Hybolin-Improved
Nandrolone Pregnancy Warnings
Nandrolone has been assigned to FDA pregnancy category X by the FDA. Anabolic steroid use, particularly during the first trimester of pregnancy, may cause virilization of the external genitalia of the female fetus. Reversible oligospermia may occur after prolonged administration or excessive dosage in male patients. There are no controlled data in human pregnancy. Nandrolone is considered contraindicated during pregnancy.
If reversible oligospermia occurs, the anabolic steroid can be discontinued and if restarted, a lower dosage should be utilized.
Nandrolone Breastfeeding Warnings
There are no data on the excretion of anabolic steroids into human milk. Because many drugs are excreted into human milk and because of the potential for adverse effects on the nursing infant, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the woman.
See also
References for pregnancy information
- (2001) "Product Information. Deca-Durabolin (nandrolone)." Organon
References for breastfeeding information
- (2001) "Product Information. Deca-Durabolin (nandrolone)." Organon
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.